Could Ofloxacin Be an Alternative to Amoxicillin–Metronidazole as an Adjunct to Non-surgical Periodontal Therapy?

Could Ofloxacin Be an Alternative to Amoxicillin–Metronidazole as an Adjunct to Non-surgical Periodontal Therapy?

Objective: Finite element stress analysis is a method in which stress formation on tissues and materials of any structure and shape can be analyzed. In this study, it is aimed to make a biblio- metric analysis of studies in prosthetic dentistry using finite element stress analysis in TR Index. Materials and Methods: Articles were obtained by searching the “finite element” keyword in the TR Index. Dentistry journals were filtered and studies were reduced to the field of dentistry. The publications were classified and recorded to include the journal name, publication year, author institutions, departments, article type, article language, and number of citations. Publications in the field of prosthetic dentistry were included in this study. Frequency analysis of the data, desc- riptive statistics and Mann–Whitney U test were performed (α = 0.05). Results: Twenty-seven studies, including 2 reviews and 25 research articles, were reached. It was seen that the most publications were in the Journal of Dental Faculty of Atatürk University and Cumhuriyet Dental Journal. Post core restorations, all-ceramic crowns, maxillofacial prostheses, and implant-sup- ported prostheses were the subject of the studies, 13 of which were in Turkish and 14 in English. Conclusion: Finite element stress analysis is a preferred method in prosthetic dentistry studies. The field of implantology stands out in this sense. National studies using this method have shown a significant increase in the last decade. The language had no significant effect on the number of citations of the publications. Keywords: Bibliometrics, prosthodontics, finite element analysis, dentistry, database ÖZ Amaç: Sonlu elemanlar stres analizi (SESA) herhangi bir yapı ve şekle sahip dokular ve materyaller üzerindeki stres oluşumunun analiz edilebildiği bir yöntemdir. Bu çalışmada TR Dizin’de SESA kul- lanan Protetik Diş Tedavisi çalışmalarının bibliyometrik incelemesinin yapılması amaçlanmıştr. Gereç ve Yöntem: TR Dizin’de ‘sonlu elemanlar’ ve ‘finite element’ anahtar kelimeleri aranarak yayınlar elde edilmiştir. Diş hekimliği dergileri filtrelenerek çalışmalar diş hekimliği alanına indirgenmiştir. Yayınlar dergi adı, yayın yılı, yazar kurumları, anabilim dalları, makale türü, makale dili, atıf sayısı bilgilerini içerecek şekilde sınıflandırılarak kaydedildi. Protetik Diş Tedavisi alanında yapılan yayınlar bu çalışmaya dahil edildi. Verilerin değerlendirilmesi için tanımlayıcı istatistik, frekans analizi ve Mann–Whitney U testi yapıldı (α = 0,05). Bulgular: İkisi derleme, yirmi beşi araştırma makalesi olmak üzere yirmi yedi çalışmaya ulaşıldı. En fazla yayının Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi ve Cumhuriyet Dental Journal derg- ilerinde yer aldığı görüldü. On üçü Türkçe, on dördü İngilizce olarak hazırlanan çalışmalarda post core restorasyonlar, tam seramik kronlar, çene yüz protezleri ve implant üstü protezler konu edilmiştir. Sonuç: SESA Protetik Diş Tedavisi çalışmalarında tercih edilen bir yöntemdir. İmplantoloji alanı bu anlamda öne çıkmaktadır. Bu yöntemi kullanan ulusal çalışmalar son on yılda önemli bir artış göstermiştir. Makale dilinin yayınların atıf sayısına anlamlı bir etkisi bulunamamıştır. Anahtar Kelimeler: Bibliometri, protetik diş tedavisi, sonlu elemanlar analizi, diş Hekimliği, veri tabanı

___

  • 1. Cosgarea R, Heumann C, Juncar R, et al. One year results of a rand- omized controlled clinical study evaluating the effects of non-surgi- cal periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronid azole. PLoS One. 2017;12(6):e0179592. [CrossRef]
  • 2. Heta S, Robo I. IThe side effects of the most commonly used group of antibiotics in periodontal treatments. Med Sci (Basel). 2018;6(1):6- 11. [CrossRef]
  • 3. World Health Organization Report on Surveillance of Antibiotic Con- sumption. World Health Geneva: Organization. Available at: https:// apps.who.int/iris/handle/10665/277359. Accessed March 28, 2023.
  • 4. Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunc- tive effect of systemic antimicrobials in periodontitis therapy. A sys- tematic review and meta-analysis. J Clin Periodontol. 2020;47(suppl 22):257-281. [CrossRef]
  • 5. Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol. 2014;85(1): 160-169. [CrossRef]
  • 6. Kleinfelder JW, Mueller RF, Lange DE. Fluoroquinolones in the treat- ment of Actinobacillus actinomycetemcomitans-associated perio- dontitis. J Periodontol. 2000;71(2):202-208. [CrossRef]
  • 7. Ishikawa I, Umeda M, Laosrisin N. Clinical, bacteriological, and immuno- logical examinations and the treatment process of two Papillon-Lefevre syndrome patients. J Periodontol. 1994;65(4):364-371. [CrossRef]
  • 8. Takahashi N, Ishihara K, Kimizuka R, Okuda K, Kato T. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Oral Microbiol Immunol. 2006;21(6):366-371. [CrossRef]
  • 9. Jain S, Rathod N, Nagi R, et al. Antibacterial effect of aloe vera gel against oral pathogens: an in-vitro study. J Clin Diagn Res. 2016;10(11):ZC41-ZC44. [CrossRef] 10. Ogawa T, Kamoi H, Kanda M, et al. Application of antibacterial agents for periodontopathic bacteria. J Oral Ther Pharmaco. 2002;21(2):47- 52. [CrossRef]
  • 11. Miyake Y, Onoe T, Sagawa H, Takamori A, Suginaka H. In vitro anti- bacterial activity of ofloxacin against periodontal disease-associated bacteria. J Periodont Res. 1988;23(3):222-223. [CrossRef]
  • 12. Inoue K, Kumakura S, Uchida M, Tsutsui T. Effects of eight antibacte- rial agents on cell survival and expression of epithelial-cell- or cell- adhesion-related genes in human gingival epithelial cells. J Periodont Res. 2004;39(1):50-58. [CrossRef]
  • 13. Omori N, Kobayashi H, Tsutsui T. Quantitative comparison of cyto- cidal effects of tetracyclines and fluoroquinolones on human perio- dontal ligament fibroblasts. J Periodont Res. 1999;34(6):290-295. [CrossRef] 14. Sasaki J, Uematsu M, Sakamoto H, et al. Comparative clinical study of ofloxacin (OFLX) with talampicillin hydrochloride (TAPC) in the treatment of oral infections. J Oral Ther Pharmaco. 1987;6(1):45-61.[CrossRef]
  • 15. Sasaki J, Morihana T, Uematsu M, et al. Clinical evaluation of ofloxacin in the treatment of oral infections. JOral Ther Pharmaco. 1986;5(2):78-86. [CrossRef]
  • 16. Lamp KC, Bailey EM, Rybak MJ. Ofloxacin clinical pharmacokinetics. Clin Pharmacokinet. 1992;22(1):32-46. [CrossRef]
  • 17. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva: World Health Organization. Available at: https://apps.who.int/iris/handle/10665/42330. Accessed March 28, 2023.
  • 18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6. [CrossRef]
  • 19. Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduc- tion and key changes from the 1999 classification. J Periodontol. 2018;89(1)(suppl 1):S1-S8. [CrossRef]
  • 20. Sánchez-Pérez A, Moya-Villaescusa MJ, Caffesse RG. Tobacco as a risk factor for survival of dental implants. J Periodontol. 2007;78(2):351-359. [CrossRef]
  • 21. Greenstein G. The role of bleeding upon probing in the diagnosis of periodontal disease. A literature review. J Periodontol. 1984;55(12): 684-688. [CrossRef]
  • 22. Abduljabbar T, Javed F, Kellesarian SV, Vohra F, Romanos GE. Effect of Nd:YAG laser-assisted non-surgical mechanical debridement on clinical and radiographic peri-implant inflammatory parameters in patients with peri-implant disease. J Photochem Photobiol B. 2017;168:16-19. [CrossRef]
  • 23. Feres M, Soares GM, Mendes JA, et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic perio- dontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012;39(12):1149-1158. [CrossRef]
  • 24. Jiang J, He D. Observation on efficacy of ofloxacin combined with metronidazole in treatment of periodontitis. Eval Anal Drug Use Hosp China. 2017;17(1):45-46.
  • 25. Yamagami H, Takamori A, Sakamoto T, Okada H. Intrapocket chemo- therapy in adult periodontitis using a new controlled-release insert containing ofloxacin (PT-01). J Periodontol. 1992;63(1):2-6. [CrossRef]
  • 26. Higashi K, Seike M, Mitani Y, et al. Concentration of ofloxacin in human gingival crevicular fluid after oral administration of Tarivid. J Periodont Res. 1989;24(6):409-411. [CrossRef]
  • 27. Yang H, Wang X, Xu Y, Zhang J. Clinical effects of metronidazole-o floxacin gel as an adjunct to conventional therapy for periodontitis. Hua Xi Kou Qiang Yi Xue Za Zhi. 2001;19(1):35-37.
  • 28. Heitz-Mayfield LJ. Systemic antibiotics in periodontal therapy. Aust Dent J. 2009;54(1)(suppl 1):S96-101. [CrossRef]
  • 29. Tenenbaum H, Jehl F, Gallion C, Dahan M. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol. 1997;24(11):804-807. [CrossRef]
  • 30. Britt MR, Pohlod DJ. Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J Periodontol. 1986;57(2):104-107. [CrossRef] 31. Pretzl B, Sälzer S, Ehmke B, et al. Administration of systemic antibi- otics during non-surgical periodontal therapy-a consensus report. Clin Oral Investig. 2019;23(7):3073-3085. [CrossRef]
  • 32. van Winkelhoff AJ. Antibiotics in periodontics: are we getting some- where? J Clin Periodontol. 2005;32(10):1094-1095. [CrossRef]
  • 33. Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community bio- mass and inflammation. ISME J. 2013;7(5):1016-1025. [CrossRef]
  • 34. Fujise K, Kikuchi Y, Kokubu E, Okamoto-Shibayama K, Ishihara K. Effect of extracytoplasmic function sigma factors on autoaggrega- tion, hemagglutination, and cell surface properties of Porphy- romonas gingivalis. PLoS One. 2017;12(9):e0185027. [CrossRef] 35. Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S. Antibac- terial activity of moxifloxacin on bacteria associated with periodon- titis within a biofilm. J Med Microbiol. 2014;63(2):284-292. [CrossRef]
  • 36. Veloo AC, Seme K, Raangs E, et al. Antibiotic susceptibility profiles of oral pathogens. Int J Antimicrob Agents. 2012;40(5):450-454. [CrossRef]
  • 37. Kimura S, Toda H, Shimabukuro Y, et al. Topical chemotherapy in human periodontitis using a new controlled-release insert contain- ing ofloxacin. I. Microbiological observation. J Periodont Res. 1991;26(1):33-41. [CrossRef]